https://seekingalpha.com/article/4699073-iwmy-that-yield-is-too-good-to-be-true?source=feed_tag_etf_portfolio_strategy
Jun 13, 2024 -
0
sa:-427855162029488267
0
https://www.zacks.com/stock/news/2287805/wall-street-analysts-think-archer-aviation-achr-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2287805
Jun 13, 2024 - According to the average brokerage recommendation (ABR), one should invest in Archer Aviation (ACHR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
zc:6578919091317585455
0
https://www.zacks.com/stock/news/2287804/wall-street-analysts-think-vistra-vst-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2287804
Jun 13, 2024 - Based on the average brokerage recommendation (ABR), Vistra (VST) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
zc:-8244221931220085853
0
https://www.zacks.com/stock/news/2287811/wall-street-analysts-think-fiverr-fvrr-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2287811
Jun 13, 2024 - Based on the average brokerage recommendation (ABR), Fiverr (FVRR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
zc:239544404019663372
0
https://www.zacks.com/stock/news/2287810/kla-klac-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2287810
Jun 13, 2024 - The average brokerage recommendation (ABR) for KLA (KLAC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
zc:4885096134329477364
0
https://www.zacks.com/stock/news/2287714/what-makes-cadeler-cdlr-a-good-fit-for-trend-investing?cid=CS-ZC-FT-tale_of_the_tape|recent_price_strength_screen-2287714
Jun 13, 2024 - Cadeler (CDLR) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
zc:-7068723901610550769
0
https://www.zacks.com/stock/news/2287820/iea-s-monthly-oil-market-report-these-are-the-key-takeaways?cid=CS-ZC-FT-analyst_blog|industry_focus-2287820
Jun 13, 2024 - Despite IEA's somewhat tepid oil demand view, we believe the space is still a good one for investors to take a position in. We suggest buying stocks like SUN, PUMP and TUWOY.
zc:3347759776213791409
0
https://seekingalpha.com/article/4698972-evg-a-good-choice-for-income-but-may-underperform-a-regular-bond-fund?source=feed_tag_etf_portfolio_strategy
Jun 12, 2024 - Eaton Vance Short Duration Diversified Income Fund offers high yield, strong price performance, leverage for yield boost. Click for my EVG CEF update.
0
sa:-310898273376877699
0
https://www.zacks.com/stock/news/2287491/snap-on-s-sna-growth-strategies-seem-good-apt-to-hold?cid=CS-ZC-FT-analyst_blog|rank_focused-2287491
Jun 12, 2024 - Snap-on's (SNA) performance benefits from strategic initiatives, such as enhancing the franchise network, cost-control efforts and increasing brand awareness.
zc:-2415985668891544845
0
https://seekingalpha.com/news/4115228-cerevel-therapeutics-gains-after-abbvie-says-making-good-progress-with-ftc?source=feed_sector_healthcare
Jun 12, 2024 - Financial writer reports 1.5% rise in Cerevel Therapeutics (CERE) after Abbvie (ABBV) reaffirms planned acquisition timeline and progress with FTC review.
0
sa:-8816007864951678281
0